The recently published article in SPIEGEL highlights a concerning issue: The avian flu H5N1 has claimed a human life in the USA. A stark reminder of how real the danger of future pandemics is. ๐๐ ๐ ๐๐ฐ๐ผ๐๐ฎ๐ง๐ฒ๐ฐ, ๐๐ฒ ๐ต๐ฎ๐๐ฒ ๐ฎ ๐บ๐ถ๐๐๐ถ๐ผ๐ป: We are developing a therapeutic solution against H5N1 that could help curb such epidemics and … Read more
On 29-30 August 2024, the Virus Biology and Biophysics Network gathered at the Helmholtz Centre for Infection Research in Braunschweig. MucosaTec GmbH proudly participated in this event as a sponsor and actively attended the talks, contributing to the exchange of groundbreaking research aimed at advancing the understanding of viral infections. With its innovative antiviral platform, … Read more
MucosaTec is among the final six candidates for this year’s Innovation Prize of the BioRegions in Germany, which aims to promote the economic utilization of modern biotechnologies. We will be presenting at the German Biotech Days on the 16th of April in Berlin and are incredibly excited to be part of this journey.
The local newspaper “Der Teckbote” has an affectionate report about a son of the city Kirchheim unter Teck – Dr. Daniel Lauster. The founding of his research group at the Freie University of Berlin and his “unappetizing” research topics are reported in detail. As unappetizing – with a wink – they mention the general research … Read more
A detailed report on three winners of the challenge from SPRIND – the Federal Agency for Disruptive Innovation – Germany on the topic of “broad-spectrum antivirals” appears in the blog of the magazine “Laborjournal”. The first thing in the article is to introduce and explain Dr. Daniel Lauster and his research project at the Freie … Read more
ยฉ COPYRIGHT MUCOSATEC
